Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Community prevalence of antibodies to SARS-CoV-2 and correlates of protective immunity in an Indian metropolitan city

View ORCID ProfileAurnab Ghose, View ORCID ProfileSankar Bhattacharya, Arun S. Karthikeyan, Abhay Kudale, Joy M. Monteiro, Aparna Joshi, View ORCID ProfileGuruprasad Medigeshi, Gagandeep Kang, Vineeta Bal, Satyajit Rath, L. S. Shashidhara, Jacob John, Susmita Chaudhuri, Aarti Nagarkar
doi: https://doi.org/10.1101/2020.11.17.20228155
Aurnab Ghose
1Biology, Indian Institute of Science Education and Research (IISER) Pune, Dr. Homi Bhabha Road, Pune 411008, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aurnab Ghose
  • For correspondence: aurnab@iiserpune.ac.in
Sankar Bhattacharya
2Translational Health Science and Technology Institute (THSTI), NCR Biotech Science Cluster, 3rd Milestone, Gurgaon-Faridabad Expressway, Faridabad 121001, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sankar Bhattacharya
Arun S. Karthikeyan
3The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College Vellore (CMC) Vellore, Ida Scudder Road, Vellore, Tamil Nadu 632002, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhay Kudale
4Interdisciplinary School of Health Sciences, Savitribai Phule Pune University (SPPU), Ganeshkhind, Pune 411007, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joy M. Monteiro
5Earth and Climate Sciences, Indian Institute of Science Education and Research (IISER) Pune, Dr. Homi Bhabha Road, Pune 411008, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aparna Joshi
6Climate Change Education Programme, Indian Institute of Science Education and Research (IISER) Pune, Dr. Homi Bhabha Road, Pune 411008, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guruprasad Medigeshi
2Translational Health Science and Technology Institute (THSTI), NCR Biotech Science Cluster, 3rd Milestone, Gurgaon-Faridabad Expressway, Faridabad 121001, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Guruprasad Medigeshi
Gagandeep Kang
3The Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College Vellore (CMC) Vellore, Ida Scudder Road, Vellore, Tamil Nadu 632002, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vineeta Bal
1Biology, Indian Institute of Science Education and Research (IISER) Pune, Dr. Homi Bhabha Road, Pune 411008, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satyajit Rath
1Biology, Indian Institute of Science Education and Research (IISER) Pune, Dr. Homi Bhabha Road, Pune 411008, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. S. Shashidhara
1Biology, Indian Institute of Science Education and Research (IISER) Pune, Dr. Homi Bhabha Road, Pune 411008, India
6Climate Change Education Programme, Indian Institute of Science Education and Research (IISER) Pune, Dr. Homi Bhabha Road, Pune 411008, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob John
7Department of Community Health, Christian Medical College Vellore (CMC) Vellore, Ida Scudder Road, Vellore, Tamil Nadu 632002, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susmita Chaudhuri
2Translational Health Science and Technology Institute (THSTI), NCR Biotech Science Cluster, 3rd Milestone, Gurgaon-Faridabad Expressway, Faridabad 121001, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aarti Nagarkar
4Interdisciplinary School of Health Sciences, Savitribai Phule Pune University (SPPU), Ganeshkhind, Pune 411007, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objectives To assess seroprevalence of anti-SARS-CoV-2 antibodies in a densely populated urban Indian settings and its implications for disease trends and protective immunity.

Design Cross-sectional sero-epidemiological survey linked with administrative reporting of COVID-19 testing data.

Settings Pune city in western India

Main outcome measure Prevalence of anti-SARS-CoV-2 spike protein antibodies were estimated and along with correlates of virus neutralisation and other immune and inflammatory markers.

Results Seropositivity was extensive (51·3%; 95%CI 39·9 to 62·4) but varied widely in the five localities tested, ranging from 35·8% to 66·4%. Seropositivity was higher in crowded living conditions in the slums (OR 1·91), and was lower in those 65 years or older (OR 0·59). The infection-fatality ratio was estimated at 0.21%. Post survey, COVID-19 incidence was lower in areas noted to have higher seroprevalence. Substantial virus-neutralising activity was observed in seropositive individuals, but with considerable heterogeneity in the immune response and possible age-dependent diversity in the antibody repertoire.

Conclusion Despite crowded living conditions having facilitated widespread transmission, the variability in seroprevalence in localities that are in geographical proximity indicates a heterogenous spread of infection. Declining infection rates in areas with high seropositivity suggest population-level protection. It is also supported by substantial neutralising activity in asymptomatically infected individuals. This is the first report of a significantly high proportion of protective immune response among asymptomatic individuals in the population. The heterogeneity in antibody levels and neutralisation capacity indicates the existence of immunological sub-groups of functional interest.

Trial registration Registered with the Clinical Trials Registry of India (CTRI/2020/07/026509)

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

CTRI/2020/07/026509

Funding Statement

The study was supported by the Persistent Foundation, Pune, India. The funding agency had no involvement in any aspect of the study. No other funding has been received by the authors or their institutions regarding this study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Institutional Ethics Committee of SPPU (SPPU/IEC/2020/82), IISER Pune (IECHR/Admin/2020/005) and THSTI (THS1.8.1(106))

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data is available on reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted November 30, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Community prevalence of antibodies to SARS-CoV-2 and correlates of protective immunity in an Indian metropolitan city
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Community prevalence of antibodies to SARS-CoV-2 and correlates of protective immunity in an Indian metropolitan city
Aurnab Ghose, Sankar Bhattacharya, Arun S. Karthikeyan, Abhay Kudale, Joy M. Monteiro, Aparna Joshi, Guruprasad Medigeshi, Gagandeep Kang, Vineeta Bal, Satyajit Rath, L. S. Shashidhara, Jacob John, Susmita Chaudhuri, Aarti Nagarkar
medRxiv 2020.11.17.20228155; doi: https://doi.org/10.1101/2020.11.17.20228155
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Community prevalence of antibodies to SARS-CoV-2 and correlates of protective immunity in an Indian metropolitan city
Aurnab Ghose, Sankar Bhattacharya, Arun S. Karthikeyan, Abhay Kudale, Joy M. Monteiro, Aparna Joshi, Guruprasad Medigeshi, Gagandeep Kang, Vineeta Bal, Satyajit Rath, L. S. Shashidhara, Jacob John, Susmita Chaudhuri, Aarti Nagarkar
medRxiv 2020.11.17.20228155; doi: https://doi.org/10.1101/2020.11.17.20228155

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (166)
  • Anesthesia (49)
  • Cardiovascular Medicine (447)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (188)
  • Epidemiology (5196)
  • Forensic Medicine (3)
  • Gastroenterology (192)
  • Genetic and Genomic Medicine (746)
  • Geriatric Medicine (76)
  • Health Economics (210)
  • Health Informatics (689)
  • Health Policy (350)
  • Health Systems and Quality Improvement (221)
  • Hematology (98)
  • HIV/AIDS (161)
  • Infectious Diseases (except HIV/AIDS) (5788)
  • Intensive Care and Critical Care Medicine (353)
  • Medical Education (101)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (754)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (140)
  • Occupational and Environmental Health (230)
  • Oncology (473)
  • Ophthalmology (149)
  • Orthopedics (37)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (138)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (135)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (851)
  • Public and Global Health (1983)
  • Radiology and Imaging (340)
  • Rehabilitation Medicine and Physical Therapy (154)
  • Respiratory Medicine (282)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (74)
  • Surgery (107)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)